跳至主要内容
临床试验/NCT02529475
NCT02529475终止4 期

Evaluation of Inner Ear and Brain Structures With Contrast-enhanced MRI in Healthy Subjects (HYDROPS)

University Hospital, Grenoble3 个研究点 分布在 1 个国家目标入组 25 人开始时间: 2016年2月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
终止
发起方
入组人数
25
试验地点
3
主要终点
Gadolinium enhancement in inner ear structures as measured by MR T1 Weighted Imaging

研究概览

简要总结

  • This prospective study aims to better characterize inner ear's perilymphatic structures with Magnetic Resonance Imaging using contrast media and delayed injection in healthy subjects
  • MR Perfusion Imaging will be assess in both cochlea as well
  • Primary auditory brain pathways will be evaluated through MR diffusion imaging

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
40 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Major subjects of over 40 years (mean age of Meniere's disease 40 to 50 years)
  • Informed consent signed
  • Medical examination performed prior to participation in research
  • Patients without history of inner ear disease
  • Recipient of a French social security scheme

排除标准

  • Patients minors
  • Patients on a legal protection regime type guardianship
  • Respiratory pathologies, cardiovascular, renal, diabetes
  • Claustrophobia
  • Contraindications to exposure to a magnetic field
  • Contraindications to injecting Dotarem ®

研究组 & 干预措施

Gadoteric acid

Experimental

Gadoteric acid 0.2 mmol/kg

干预措施: Gadoteric acid (Drug)

结局指标

主要结局

Gadolinium enhancement in inner ear structures as measured by MR T1 Weighted Imaging

时间窗: One MR scan (4 hours)

次要结局

未报告次要终点

研究者

发起方
University Hospital, Grenoble
申办方类型
Other
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验